BTLA Recombinant Protein
Selected Variant
96-067
Size: 0.1 mg
Product Specifications
Background
B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.
CAS Number
9000-83-3
NCBI Gene ID
151888
Swiss Prot
Q7Z6A9
Accession Number
NP_001078826.1
Tag
C-Fc Tag
Type
Recombinant Proteins
Source
HEK293 cells
Field of Research
Immunology, Innate Immunity, Obesity
Purity
>90% as determined by SDS-PAGE.
Buffer
Tris with Glycine, Arginine and NaCl, pH7.5
Shipping Conditions
Room Temp
Storage Conditions
Lyophilized Protein should be stored at -20˚ C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚ C or -70˚ C. Avoid repeated freeze-thaw cycles.
Calculated Molecular Weight
38.7 kDa
Applications Notes
This recombinant protein can be used for WB. For research use only.
NCBI Official Name
B and T lymphocyte associated
NCBI Organism
Homo sapiens
Background Reference 01
Watanabe N., et al., 2003, Nat. Immunol. 4:670-679.
Background Reference 02
Gavrieli M., et al., 2003, Biochem. Biophys. Res. Commun. 312:1236-1243.
Background Reference 03
Sedy J.R., et al., 2005, Nat. Immunol. 6:90-98.
Other Product Names
BTLA, CD272
Tested Applications
WB
Species
Human
Physical Properties
Lyophilized
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog